Pathoquest_logo
  • About Us
    • Why PathoQuest
    • Leadership Team
    • Strategic Partnerships
    • Client Testimonials
    • Careers
  • Modalities
    • mAbs and Recombinant Proteins
    • Viral Vectors
    • Cell Therapies
    • Vaccines
    • RNA Therapies
    • Cultivated Meat
  • Services
    • Adventitious Virus Testing
    • In Vivo Replacement
    • Cell Line Characterization
    • Identity Confirmation
    • HLA Genotyping
    • Integration Site Analysis
    • Raw Material Testing
  • iDTECT® Platform
  • 3Rs
  • Quality & Regulatory
    • Quality
    • Regulatory
  • Resources
    • Publications
    • Brochures and Posters
    • Webinars and Talks
    • Our One-Minute Series on NGS
  • News
  • Contact

Webinar – APR 22, 2025 | Advancing Biomanufacturing Quality Control with GMP Next Generation Sequencing (NGS): Regulatory Insights and Industry Case Study

by Sabrina | Apr 4, 2025 | News

JOINT WEBINAR   PathoQuest & Avid Bioservices   Advancing Biomanufacturing Quality Control with GMP Next Generation Sequencing (NGS) Regulatory Insights and Industry Case Study  22nd April 2025  10:00am EDT / 7:00am PDT / 3:00pm BST / 4:00pm CEST Presented...

New Article by CRL on Next-Generation Sequencing (NGS) for Adventitious Virus Testing

by Aicha Ngoulou | Sep 25, 2024 | News

This article from Charles River Laboratories dives into how NGS is transforming adventitious virus testing, offering greater sensitivity and comprehensive detection compared to traditional methods. As NGS continues to play a pivotal role in biosafety, this insight...

Webinar – OCT 1, 2024 | Adventitious Agent Testing For MMV: How Much Do We Really Know?

by Aicha Ngoulou | Sep 11, 2024 | News

CLICK HERE TO BOOK YOUR FREE SEAT JOINT WEBINAR Takeda, PathoQuest & Charles River Laboratories   Adventitious Agent Testing For MMV: How Much Do We Really Know?   01st October 2024 10:00am EDT / 7:00am PDT / 3:00pm BST / 4:00pm CEST Presented by: Maria...

Welcome to Stanley Prince, Chief Commercial Officer at PathoQuest!

by Delphine Gricourt | Jul 25, 2024 | News

Welcome to Stanley Prince,Chief Commercial Officer at PathoQuest!  We are delighted to announce the arrival of Stanley Prince as Chief Commercial Officer! With 20 years of experience in vaccines, biologics and cell/gene therapies, Stanley Prince’s expertise in...

EFPIA Releases Position Paper on Next Generation Sequencing (NGS) for Enhanced Viral Safety in Biopharmaceuticals

by Aicha Ngoulou | Jun 26, 2024 | News

New EFPIA Position Paper on Next Generation Sequencing (NGS) for Adventitious Virus Detection  The EFPIA (European Federation of Pharmaceutical Industries and Associations) has released a pivotal position paper on the use of Next Generation Sequencing (NGS) for...

Biopharma testing: The right time to move to new standards?

by Aicha Ngoulou | May 22, 2024 | News

Pathoquest is thrilled to contribute to the transformative shift in biologics testing, as highlighted in the insightful article by Labiotech.eu. The move towards faster, safer and non-animal based assay is not just a trend; it’s the future of ensuring safety and...
« Older Entries
Next Entries »

Home » News » Page 2

T: +33 (0)1 70 82 17 90
T: +1 484 212 9360

Copyright © 2026 – PathoQuest | Cookies Policy | Privacy Policy

T: +33 (0)1 70 82 17 90
T: +1 484 212 9360

Copyright © 2026 – PathoQuest | Cookies Policy | Privacy Policy

Cleantalk Pixel
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

Explore our full library of scientific resources

Access our latest thinking

Name(Required)
By submitting this form, PathoQuest will use the personal data you provide to handle your request. Read our Privacy Notice for more information.(Required)